IVM AND EARLY PROTECTION OF THE ENDOTHELIUM IN SARS-CoV-2 INFECTION
The following bodies of work should be integrated into your thesis, building your case.
Bruce Patterson's work: https://www.youtube.com/watch?v=h2xyWiMS2Q0
IVM is on the list of about 8 therapeutics that are used to address about 14 key biomarkers that were identified by AI machine learning techniques derived from a large candidate set of biomarkers taken from key groups of people with long haul type syndromes: Long Haul Post COVID, Long Haul Post COVID vaccine, Long haul ME/CFS chronic fatigue, long haul post Lyme, fibromyalgia. The results show the commonalities and differences between these syndromes. There is a key finding of persistent antigen fragments in monocytes driving COVID syndromes. Of the 14 biomarkers needed to treat, and about 8 compounds that Patterson and colleagues are focusing on, Ivermectin is one of them.
Also papers by my friend David Scheim:
(I commented on the second manuscript before it went out.)
The first talks about how a mild cold virus turned deadly by undermining a process to prevent hemagglutination. Clumping of red blood cells.
From Cold to Killer
The second paper discusses how in vitro IVM is a tool that will undo or return to healthy state the rouleaux formations in blood cells if at at their early stage. An exciting find.
A Deadly Embrace
David also published a review article on IVM for COVID with some well known folks:
Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19
Santin, Scheim, McCullough, Yagisawa, Borody
A few more papers are in the works, will keep you posted.
And the evidence mounts ... meanwhile, covid patients are told to take dangerous horse medicine. - "Molnupiravir began as a possible therapy for Venezuelan equine encephalitis virus at Emory University’s non-profit company DRIVE (Drug Innovation Ventures at Emory) in Atlanta." https://www.nature.com/articles/d41586-021-02783-1
Que narrative pivot to "just because it was originally developed for horses doesn't mean it's horse medicine", from the same gaslighters who brought us "you're not a horse, you're not a cow, seriously y'all, stop it". (Or they'll hope no one notices the equine detail .. or the mutagenic potential .. ( what could go wrong? ))
Walter, If this holds true isn't this a case for IVM as importantly for prophylaxis use?